CTSS and viral infectious disease: One screen aimed to identify factors associated with deficiencies in lysosomal degradation of RNF152, while the other utilized defects in cathepsin-mediated viral infections (including SARS-CoV-2) as criteria (Richards et al., 2022; Zhang et al., 2022a).